Lumbar Disc Herniation(LDH)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. In accordance with the diagnostic criteria of acute LDH. 2. Aged >= 18 and = 40mm; 5. Volunteer to participate in this trial, can cooperate with the treatment and fill in the questionnaire, and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe LDH in line with surgical indications, such as cauda equina syndrome and progressive muscle weakness of lower limbs; 2. Patients with spinal tumor, lumbar tuberculosis, severe osteoporosis, lumbar vertebral fracture, lumbar spondylolisthesis, sacroiliac joint disease, piriformis syndrome, gluteal nerve entrapment, severe developmental or degenerative spinal stenosis; 3. Patients with severe scoliosis or congenital lumbar deformity and loss of normal activity; 4. Patients with severe hypertension or severe organic diseases of heart, liver and kidney; 5. Patients with skin damage, ulceration or skin diseases; 6. Lactating or pregnant women, mental patients; 7. Patients with bleeding tendency or blood disease; 8. Patients with needle sickness or blood-injury phobia; 9. Participating in other clinical trials; 10. Received lumbar disc surgery within half a year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| JOA;ODI;VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug combination;Lumbar motion angle;Quantization Table for TCM Syndrome Differentiation;Treatment discontinuation time (Average course of treatment);Treatment expectation and satisfaction;EQ-5D-5L;Straight leg elevation angle;Overall efficacy evaluation; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine